Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Croda International ( (GB:CRDA) ) has shared an announcement.
Croda International reported first-quarter 2026 sales of £431m, up 1% at constant currency and broadly in line with expectations against a strong prior-year comparator. Growth in Beauty Actives, fragrances and flavours, and home care within its Consumer Care division offset weaker performance in Life Sciences, notably an 8% constant-currency decline in Crop Protection, while Industrial Specialties also saw modest volume pressure.
Regionally, Latin America delivered the strongest growth thanks to resilient agriculture demand and robust Consumer Care sales, while North America lagged due to normalising crop protection demand, weather-related disruption and consumer pressure. Management said the Middle East conflict has not had a material impact so far, reaffirmed its full-year 2026 outlook, and highlighted that its transformation programme is on track to drive margin improvements and improved returns, though currency movements could trim reported operating profit by about £4m this year.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £34.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Spark’s Take on CRDA Stock
According to Spark, TipRanks’ AI Analyst, CRDA is a Neutral.
The score reflects solid financial stability (manageable leverage and positive cash generation) and supportive technical momentum, balanced against a demanding valuation (high P/E) and execution risk highlighted on the earnings call (exceptional charges and segment volatility despite improving guidance and transformation progress).
To see Spark’s full report on CRDA stock, click here.
More about Croda International
Croda International is a U.K.-based specialty chemicals group supplying ingredients and technologies for consumer care, life sciences and industrial applications. Its portfolio spans beauty actives, personal and home care ingredients, fragrances and flavours, as well as products for pharmaceuticals, crop protection and seed enhancement, serving global consumer and industrial markets.
Average Trading Volume: 569,491
Technical Sentiment Signal: Hold
Current Market Cap: £4.24B
See more data about CRDA stock on TipRanks’ Stock Analysis page.